Skip to content
  • About
  • Shop
  • News
  • Contact Us
Search
NECA Logo
  • NET Nurse
  • Donate
  • What are NETs?
    • What are Neuroendocrine Cancers?
    • What are Pheos & Paras?
    • NET Symptoms
    • NET Types
    • Causes
    • Treatments
    • Grades
    • Diagnosis
    • Prognosis
    Consider the Grey Area
  • Patients & Carers
    • Patient & Carer Support
    • Patient Resources
    • Optimal Care Pathway
    • NET Nurse
    • Patient Stories
    • Share your Story
    • Australian NET Specialists
    • Clinical Trials
    • Living with NETS
    • Specialist Support Services
    Consider the Grey Area
  • Healthcare Professionals
    • Optimal Care Pathway
    • Professional Learning
    • Patient Referral
    • Clinical Trials
    • NET Symptoms
    • Australian NET Specialists
    • Request an In-Service
    • PLANET Registry
    • Order Booklets & Resources
    Consider the Grey Area
  • Get Involved
    • Advocate for Us
    • Share your Story
    • Donate
    • Fundraise
    • Events
    • In Memoriam
    • Corporate Partners
    • Gifts & Wills
    • Volunteer
    Senate MailChimp
  • NCD 2025
NET Nurse
Donate

Home » News » Real-world management and patient perspectives on QOL with neuroendocrine tumours: An ANZ perspective

Real-world management and patient perspectives on QOL with neuroendocrine tumours: An ANZ perspective

  • July 27, 2021

On 2 September 2020 a webinar was held titled “NET 2020” for Health Professionals and was sponsored by Novartis.

There were around 120 attendees at the event from across Australia which had a panel of NET Specialists providing information about current treatment options, an opportunity to take part in an in-depth discussion of a functional GEPNET patient case, a debate on the optimal clinical approach for non-functional GEPNET, and new data on quality of life issues affecting NET patients to improve supportive care. This article provides a summary of the presentations at the event which will be extremely interesting to the medical community.

Click the button below for full article.

Download here

Share this post

Recent posts

NECA attends Professionals Uplifting Patient Partnership (PUPP)’s final event of the year

December 5, 2025

Navigating Extrapulmonary Neuroendocrine Carcinoma: COR2ED Resource Featuring Insights from NECA CEO Meredith Cummins

December 5, 2025

Nuclear Medicine Round Table

November 27, 2025

Celebrated Chef and Slow Food Pioneer Skye Gyngell Passed Away from Neuroendocrine Cancer

November 27, 2025
Categories
  • Advocacy
  • Awareness
  • Community Events
  • Education
  • Events
  • Fundraising
  • General
  • In The Media
  • News
  • Research
  • Unicorn Events
PrevPreviousNETs Q&A 2021
NextNew Normal, Same Cancer CampaignNext

Related Posts

Navigating Extrapulmonary Neuroendocrine Carcinoma: COR2ED Resource Featuring Insights from NECA CEO Meredith Cummins

Nuclear Medicine Round Table

On Monday 17 November NECA attended the National Roundtable – Sustainable Pathways: Shaping the Future of Nuclear Medicines in Australia at Parliament House. Nuclear Medicine

Celebrated Chef and Slow Food Pioneer Skye Gyngell Passed Away from Neuroendocrine Cancer

Australian born chef Skye Gyngell, one of the most influential voices in the slow food movement and a pioneer of seasonal, sustainable cooking, has died

Attribute Preferences for SSAs in NETs Among Patients, Clinicians and Nurses in Australia

Simon J Fifer   |   Karen Winkler   |   Meredith Cummins   |   Hima Cherian Read Full Article Here

View All

Subscribe to Newsletter

NECA Logo
registered charity badge

What are NETs

  • About Us
  • Our People
  • Our Ambassadors
  • Consumer Advisory Group
  • International Advisory Panel
  • Governance & Policies
  • About Us
  • Our People
  • Our Ambassadors
  • Consumer Advisory Group
  • International Advisory Panel
  • Governance & Policies

Patients & Carers

  • What are Neuroendocrine Cancers?​
  • Pheos and Paras
  • NET Library
  • What are Neuroendocrine Cancers?​
  • Pheos and Paras
  • NET Library

Healthcare Professionals

  • Patient resources
  • NET Nurse
  • Patient Stories
  • Australian NET Specialists
  • Current Open Clinical Trials
  • Patient resources
  • NET Nurse
  • Patient Stories
  • Australian NET Specialists
  • Current Open Clinical Trials

Get Involved

  • Shop
  • Donate
  • Volunteer
  • Current Fundraising Campaigns
  • Fundraise
  • Shop
  • Donate
  • Volunteer
  • Current Fundraising Campaigns
  • Fundraise
All charity donations to NeuroEndocrine Cancer Australia may be tax-deductible in Australia.

Registered Charity CFN 202607
© 2025 NeuroEndocrine Cancer Australia
  • Website by Five Creative
Twitter Facebook Youtube Instagram Linkedin